
Belangrijk nieuws: bemoedigende bevindingen voor borstkankerpatiënten met een kinderwens
The POSITIVE academic study was initiated to understand whether women, who desire to, can interrupt
The POSITIVE academic study was initiated to understand whether women, who desire to, can interrupt
As 2023 draws to a close, we extend our heartfelt gratitude to the European Health
In a significant step towards comprehending and addressing metastatic breast cancer, AURORA has just entered
Pink October and Breast Cancer Awareness Month have ended, underscoring global solidarity in the fight
The “Colours of India” Gala at Autoworld Brussels was a dazzling success, bringing together supporters
October 13th marks Metastatic Breast Cancer Awareness Day, a day dedicated to raising awareness about
On the occasion of the International Breast Cancer Awareness Month, the European Organisation for Research
Marathon Woman will run a marathon every day in 2024 and raise funds for BIG’s
On 26 April 2023, BIG signed an agreement with the European Health and Digital Executive
MISSING Act before they’re gone! Breast cancer research – saving lives The annual report is
ASCO 2023 Annual Meeting – 3 June 2023 We extend our warmest congratulations to Dr.
Around one in every eight women will develop breast cancer in their lifetime*. A percentage
4 June marks National Cancer Survivors Day (in the US) – a moment to recognise
The latest edition of BIG Research in Focus highlights the POSITIVE trial. Clic here to discover it.
This Saturday, on the 20th of May, the world will come together to mark International
The HERA study: a new standard of care for HER2-positive breast cancer The HERA study,
At this year’s St. Gallen Breast Cancer Congress (SGBCC, 15-18 March 2023), Professor Giuseppe Viale
Results of the final analysis of the NeoALTTO study have been published in the European
Donaties van €40 of meer per jaar komen in aanmerking voor een belastingvermindering van 45%. Dit betekent dat je donatie van €40 je slechts €22 kost.
Medegefinancierd door de Europese Unie in het kader van een operationele subsidie van het EU4Health-programma van de Europese Unie, onder subsidieovereenkomst nr. 101124555. De hier geuite ideeën en meningen komen echter uitsluitend voor rekening van de auteur(s) en geven niet noodzakelijkerwijs die van de Europese Unie of het Europese Uitvoerende Agentschap Gezondheid en digitaal beleid (HADEA) weer. Noch de Europese Unie, noch het HADEA kan ervoor aansprakelijk worden gesteld.